The role of joint nerves and mast cells in the alteration of vasoactive intestinal peptide (VIP) sensitivity during inflammation progression in rats

British Journal of Pharmacology

Volumn 145, Issue 1, 2005, Pages 104-113

  McDougall, Jason J ^a   Barin, Ali Kursat ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Arthritis; Blood flow; Knee joint nerves; Mast cells; Neurogenic inflammation; Neuropeptides; Vasoactive intestinal peptide

Indexed keywords

CROMOGLYCATE DISODIUM; UNCLASSIFIED DRUG; URETHAN; VASOACTIVE INTESTINAL POLYPEPTIDE; VASOACTIVE INTESTINAL POLYPEPTIDE ANTAGONIST; VASOACTIVE INTESTINAL POLYPEPTIDE[6-28];

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; BLOOD FLOW; CHRONIC DISEASE; CONTROLLED STUDY; DENERVATION; DISEASE COURSE; HYPEREMIA; INHIBITION KINETICS; KNEE; MALE; MAST CELL; NEUROGENIC INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT; SYNOVIOCYTE; VASODILATATION;

ANIMALS; ARTHRITIS; HINDLIMB; JOINTS; MALE; MAST CELLS; RATS; RATS, WISTAR; VASOACTIVE INTESTINAL PEPTIDE; VASODILATOR AGENTS;

EID: 18744414508     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706169     Document Type: Article

References (54)

1. ABRAMOVICI, A., DAIZADE, I., YOSIPOVITCH, Z., GIBSON, S.J. & POLAK, J.M. (1991). The distribution of peptide-containing nerves in the synovia of the cat knee joint. Histol. Histopathol., 6, 469-476.
2. ACKERMANN, P.W., LI, J., FINN, A., AHMED, M. & KREICBERGS, A. (2001). Autonomic innervation of tendons, ligaments and joint capsules. A morphologic and quantitative study in the rat. J. Orthop. Res., 19, 372-378.
3. AHMED, M., BJURHOLM, A., SCHULTZBERG, M., THEODORSSON, E. & KREICBERGS, A. (1995a). Increased levels of substance P and calcitonin gene-related peptide in rat adjuvant arthritis. A combined immunohistochemical and radioimmunoassay analysis. Arthritis Rheum., 38, 699-709.
4. AHMED, M., BJURHOLM, A., SRINIVASAN, G.R., LUNDBERG, T., THEODORSSON, E., SCHULTZBERG, M. & KREICBERGS, A. (1995b). Capsaicin effects on substance P and CGRP in rat adjuvant arthritis. Regul. Peptides, 55, 85-102.
5. BARIN, A.K. & MCDOUGALL, J.J. (2003). Endomorphin-1 causes synovial hypoaemia in rat knee joints via a capsaicin-sensitive neural pathway. Neurosci. Lett., 344, 21-24.
6. BUMA, P., ELMANS, L., VAN DEN BERG, W.B. & SCHRAMA, L.H. (2000). Neurovascular plasticity in the knee joint of an arthritic mouse model. Anat. Rec., 260, 51-61.
7. CAMBRIDGE, H. & BRAIN, S.D. (1992). Calcitonin gene-related peptide increases blood flow and potentiates plasma protein extravasation in the rat knee joint. Br. J. Pharmacol., 106, 746-750.
8. CATRE, M.G. & SALO, P.T. (1999). Quantitative analysis of the sympathetic innervation of the rat knee joint. J. Anat., 194, 233-239.
9. CAUGHEY, G.H., LEIDIG, F., VIRO, N.F. & NADEL, J.A. (1988). Substance P and vasoactive intestinal peptide degradation by mast cell tryptase and chymase. J. Pharmacol. Exp. Ther., 244, 133-137.
10. CLARK, K.E., MILLS, E.G., STYS, S.J. & SEEDS, A.E. (1981). Effects of vasoactive polypeptides on the uterine vasculature. Am. J. Obstet. Gynecol., 139, 182-188.
11. DELGADO, M., ABAD, C., MARTINEZ, C., LECETA, J. & GOMARIZ, R.P. (2001). Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease. Nat. Med., 7, 563-568.
12. DONALDSON, L.F., HARMAR, A.J., MCQUEEN, D.S. & SECKL, J.R. (1992). Increased expression of preprotachykinin, calcitonin gene-related peptide, but not vasoactive intestinal peptide messenger RNA in dorsal root ganglia during the development of adjuvant monoarthritis in the rat. Mol. Brain Res., 16, 143-149.
13. DONALDSON, L.F., MCQUEEN, D.S. & SECKL, J.R. (1995). Neuropeptide gene expression and capsaicin-sensitive primary afferents: maintenance and spread of adjuvant arthritis in the rat. J. Physiol., 486.2, 473-482.
14. DONALDSON, L.F., SECKL, J.R. & MCQUEEN, D.S. (1993). A discrete adjuvant-induced monoarthritis in the rat: effects of adjuvant dose. J. Neurosci. Methods, 49, 5-10.
15. FERRELL, W.R., LOCKHART, J.C. & KARIMIAN, S.M. (1997). Tachykinin regulation of basal synovial blood flow. Br. J. Pharmacol., 121, 29-34.
16. FERRELL, W.R., LOCKHART, J.C., KELSO, E.B., DUNNING, L., PLEVIN, R., MEEK, S.E., SMITH, A.J., HUNTER, G.D., MCLEAN, J.S., MCGARRY, F., RAMAGE, R., JIANG, L., KANKE, T. & KAWAGOE, J. (2003). Essential role for proteinase-activated receptor-2 in arthritis. J. Clin. Invest., 111, 35-41.
17. FIRESTEIN, G.S. (2001). VIP: a very important protein in arthritis. Nat. Med., 7, 537-538.
18. FOEY, A.D., FIELD, S., AHMED, S., JAIN, A., FELDMANN, M., BRENNAN, F.M. & WILLIAMS, R. (2003). Impact of VIP and cAMP on the regulation of TNF-alpha and IL-10 production: implications for rheumatoid arthritis. Arthritis Res. Ther., 5, R317-R328.
19. GRONEBERG, D.A., WELKER, P., FISCHER, T.C., DINH, Q.T., GRUTZKAU, A., PEISER, C., WAHN, U., HENZ, B.M. & FISCHER, A. (2003). Down-regulation of vasoactive intestinal polypeptide receptor expression in atopic dermatitis. J. Allergy Clin. Immunol., 111, 1099-1105.
20. HANNON, J.P., PFANNKUCHE, H.J. & FOZARD, J.R. (1995). A role for mast cells in adenosine A3 receptor-mediated hypotension in the rat. Br. J. Pharmacol., 115, 945-952.
21. HARMAR, A.J., ARIMURA, A., GOZES, I., JOURNOT, L., LABURTHE, M., PISEGNA, J.R., RAWLINGS, S.R., ROBBERECHT, P., SAID, S.I., SREEDHARAN, S.P., WANK, S.A. & WASCHEK, J.A. (1998). International Union of Pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol. Rev., 50, 265-270.
22. HEISTAD, D.D., MARCUS, M.L., SAID, S.I. & GROSS, P.M. (1980). Effect of acetylcholine and vasoactive intestinal peptide on cerebral blood flow. Am. J. Physiol.: Heart Circ. Physiol., 239, H73-H80.
23. HUANG, M., SHIRAHASE, H. & RORSTAD, O.P. (1993). Comparative study of vascular relaxation and receptor binding by PACAP and VIP. Peptides, 14, 755-762.
24. JIN, C., NARUSE, S., KITAGAWA, M., ISHIGURO, H., NAKAJIMA, M., MIZUNO, N., KO, S.B. & HAYAKAWA, T. (2001). The effect of calcitonin gene-related peptide on pancreatic blood flow and secretion in conscious dogs. Regul. Peptides, 99, 9-15.
25. JOHNSTON, B., BURNS, A.R. & KUBES, P. (1998). A role for mast cells in the development of adjuvant-induced vasculitis and arthritis. Am. J. Pathol., 152, 555-563.
26. KARIMIAN, S.M., MCDOUGALL, J.J. & FERRELL, W.R. (1995). Neuropeptidergic and autonomic control of the vasculature of the rat knee joint revealed by laser Doppler perfusion imaging. Exp. Physiol., 80, 341-348.
27. KLIMASCHEWSKI, L. (1997). VIP - a 'very important peptide' in the sympathetic nervous system? Anat. Embryol., 196, 269-277.
28. LAM, F.Y. & FERRELL, W.R. (1989). Inhibition of carrageenan-induced joint inflammation by substance P antagonist. Ann. Rheum. Dis., 48, 928-932.
29. LAM, F.Y. & FERRELL, W.R. (1993). Acute inflammation in the rat knee joint attenuates sympathetic vasoconstriction but enhances neuropeptide-mediated vasodilatation assessed by laser Doppler perfusion imaging. Neuroscience, 52, 443-449.
30. LANGLET, C., GASPARD, N., NACHTERGAEL, I., ROBBERECHT, P. & LANGER, I. (2004). Comparative efficacy of VIP and analogs on activation and internalization of the recombinant VPAC2 receptor expressed in CHO cells. Peptides, 25, 2079-2086.
31. LARSSON, J., EKBLOM, A., HENRIKSSON, K., LUNDBERG, T. & THEODORSSON, E. (1991). Concentration of substance P, neurokinin-A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis. Scand. J. Rheumatol., 20, 326-335.
32. LARSSON, L.I., FAHRENKRUG, J., SCHAFFALITZKY DE MUCKADELL, O., SUNDLER, F., HAKANSON, R. & REHFELD, J.R. (1976). Localization of vasoactive intestinal polypeptide (VIP) to central and peripheral neurons. Proc. Natl. Acad. Sci. U.S.A., 73, 3197-3200.
33. LEVINE, J.D., CLARK, R., DEVOR, M., HELMS, C., MOSKOWITZ, M.A. & BASBAUM, A.I. (1984). Intraneuronal substance P contributes to the severity of experimental arthritis. Science, 226, 547-549.
34. LEVINE, J.D., CODERRE, T.J., COVINSKY, K. & BASBAUM, A.I. (1990). Neural influences on synovial mast cell density in rat. J. Neurosci. Res., 26, 301-307.
35. LEVINE, J.D., COLLIER, D.H., BASBAUM, A.I., MOSKOWITZ, M.A. & HELMS, C.A. (1985a). Hypothesis: the nervous system may contribute to the pathophysiology of rheumatoid arthritis. J. Rheumatol., 12, 406-411.
36. LEVINE, J.D., DARDICK, S.J., ROIZEN, M.F., HELMS, C. & BASBAUM, A.I. (1986). Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J. Neurosci., 6, 3423-3429.
37. LEVINE, J.D., MOSKOWITZ, M.A. & BASBAUM, A.I. (1985b). The contribution of neurogenic inflammation in experimental arthritis. J. Immunol., 135, 843s-847s.
38. LYGREN, I., ØSTENSEN, M., BURHOL, P.G. & HUSBY, G. (1986). Gastrointestinal peptides in serum and synovial fluid from patients with inflammatory joint disease. Ann. Rheum. Dis., 45, 637-640.
39. MCDOUGALL, J.J. (2003). Involvement of sympathetic efferents but not capsaicin-sensitive afferents in nociceptin-mediated dual control of rat synovial blood flow. Am. J. Physiol.: Regul. Integr. Comp. Physiol., 284, R1477-R1485.
40. MCDOUGALL, J.J., BARIN, A.K. & MCDOUGALL, C.M. (2004). Loss of vasomotor responsiveness to the μ-opioid receptor ligand endomorphin-1 in adjuvant monoarthritic rat knee joints. Am. J. Physiol.: Regul. Integr. Comp., Physiol., 286, R634-R641.
41. MCDOUGALL, J.J., ELENKO, R.D.V. & BRAY, R.C. (1998). Cholinergic vasoregulation in normal and adjuvant monoarthritic rat knee joints. J. Auton. Nerv. System, 72, 55-60.
42. MCDOUGALL, J.J., FERRELL, W.R. & BRAY, R.C. (1999). Neurogenic origin of articular hyperemia in early degenerative joint disease. Am. J. Physiol., 276, R345-R352.
43. MCDOUGALL, J.J., KARIMIAN, S.M. & FERRELL, W.R. (1995). Prolonged alteration of sympathetic vasoconstrictor and peptidergic vasodilator responses in rat knee joints by adjuvant-induced arthritis. Exp. Physiol., 80, 349-357.
44. (8-37). Br. J. Pharmacol., 121, 1075-1080.
45. MOLINO, M., BARNATHAN, E.S., NUMEROF, R., CLARK, J., DREYER, M., CUMASHI, A., HOXIE, J.A., SCHECHTER, N., WOOLKALIS, M. & BRASS, L.F. (1997). Interactions of mast cell tryptase with thrombin receptors and PAR-2. J. Biol. Chem., 272, 4043-4049.
46. NAUKKARINEN, A., HARVIMA, I.T., AALTO, M.L. & HORSMAN-HEIMO, M. (1994). Mast cell tryptase and chymase are potential regulators of neurogenic inflammation in psoriatic skin. Int. J. Dermatol., 33, 361-366.
47. DE PAULIS, A., MARINO, I., CICCARELLI, A., DE CRESCENZO, G., CONCARDI, M., VERGA, L., ARBUSTINI, E. & MARONE, G. (1996). Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization. Arthritis Rheum., 39, 1222-1233.
48. PIOTROWSKI, W. & FOREMAN, J.C. (1985). On the actions of substance P, somatostatin, and vasoactive intestinal polypeptide on rat peritoneal mast cells and in human skin. Naunyn-Schmiedeberg's Arch. Pharmacol., 331, 364-368.
49. ROBBERECHT, P., DE NEEF, P., WAELBROECK, M., TASTENOY, M. & CHRISTOPHE, J. (1989). VIP and related peptides induce rapid homologous desensitization in the human lymphoma SUP T1 cell line. Peptides, 10, 441-446.
50. SAID, S.I. & MUTT, V. (1970). Polypeptide with broad biological activity: isolation from small intestine. Science, 169, 1217-1218.
51. SKOFITSCH, G., DONNERER, J., PETRONIJEVIC, S., SARIA, A. & LEMBECK, F. (1983). Release of histamine by neuropeptides from the perfused rat hindquarter. Naunyn-Schmiedeberg's Arch. Pharmacol., 322, 153-157.
52. TAKEBA, Y., SUZUKI, N., KANEKO, A., ASAI, T. & SAKANE, T. (1999). Evidence for neural regulation of inflammatory synovial cell functions by secreting calcitonin gene-related peptide and vasoactive intestinal peptide in patients with rheumatoid arthritis. Arthritis Rheum., 42, 2418-2429.
53. UDDMAN, R., ALUMETS, J., EDVINSSON, L., HAKANSON, R. & SUNDLER, F. (1981). VIP nerve fibres around peripheral blood vessels. Acta Physiol. Scand., 112, 65-70.
54. WILLIAMS, T.J. (1982). Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin. Br. J. Pharmacol., 77, 505-509.